| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Immunocore Holdings plc: Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response | 3 | GlobeNewswire (USA) | ||
| Fr | Immunocore Holdings plc - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Immunocore Holdings plc: Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 | 96 | GlobeNewswire (Europe) | Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 Monotherapy brenetafusp... ► Artikel lesen | |
| 30.05. | Immunocore Holdings plc: Immunocore to present at the Jefferies Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 29.05. | Immunocore Holdings plc: Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma | 42 | GlobeNewswire (Europe) | Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with FDA... ► Artikel lesen | |
| 23.05. | Immunocore Holdings plc - 8-K, Current Report | 3 | SEC Filings | ||
| 08.05. | Immunocore Holdings PLC reports results for the quarter ended in March - Earnings Summary | 2 | Reuters | ||
| 08.05. | Immunocore Holdings plc - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | Immunocore Holdings plc: Immunocore reports first quarter financial results and provides a business update | 384 | GlobeNewswire (Europe) |
Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $70.3 million in Q1 2024; continuing to expand global access with 7... ► Artikel lesen | |
| 08.05. | Immunocore Holdings plc - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 24.04. | Immunocore Holdings plc: Immunocore announces upcoming presentation and posters at ASCO 2024 | 434 | GlobeNewswire (Europe) | Immunocore announces upcoming presentation and posters at ASCO 2024 Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp (IMC-F106C targeting PRAME) to be presented... ► Artikel lesen | |
| 05.04. | Immunocore Holdings plc - 8-K, Current Report | 1 | SEC Filings | ||
| 28.02. | Immunocore Holdings plc - 8-K, Current Report | 1 | SEC Filings | ||
| 28.02. | Immunocore Holdings plc - 10-K, Annual Report | 1 | SEC Filings | ||
| 29.01. | Immunocore Holdings plc - 8-K, Current Report | 1 | SEC Filings | ||
| 02.01. | Immunocore Holdings plc - 8-K, Current Report | 4 | SEC Filings |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 4.425 |
| NVIDIA | 3.117 |
| GAMESTOP | 2.445 |
| NEL | 2.228 |
| BAYER | 1.925 |
| EVOTEC | 1.893 |
| PLUG POWER | 1.789 |
| BYD | 1.304 |
| VOLKSWAGEN | 862 |
| SUPER MICRO COMPUTER | 851 |
| DEUTSCHE LUFTHANSA | 773 |
| RHEINMETALL | 759 |
| BIONTECH | 715 |
| AIXTRON SE | 692 |
| TESLA | 555 |
| BASF | 551 |
| DEUTSCHE TELEKOM | 549 |
| PALANTIR TECHNOLOGIES | 549 |
| ALLIANZ | 547 |
| THYSSENKRUPP | 537 |
| DEUTSCHE BANK | 530 |
| OMV | 520 |
| NOVAVAX | 513 |
| SIEMENS ENERGY | 506 |
| RWE | 504 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
